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Attentional bias modification (ABM) represents one of a number of cognitive bias modification techniques which
are beginning to show promise as therapeutic interventions for emotional pathology. Numerous studies with both
clinical and non-clinical populations have now demonstrated that ABM can reduce emotional vulnerability. However,
some recent studies have failed to achieve change in either selective attention or emotional vulnerability using ABM
methodologies, including a recent randomised controlled trial by Carlbring et al. Some have sought to represent
such absence of evidence as a sound basis not to further pursue ABM as an online intervention. While these findings
obviously raise questions about the specific conditions under which ABM procedures will produce therapeutic benefits,
we suggest that the failure of some studies to modify selective attention does not challenge the theoretical and empirical
basis of ABM. The present paper seeks to put these ABM failures in perspective within the broader context of attentional
bias modification research. In doing so it is apparent that the current findings and future prospects of ABM are in fact very
promising, suggesting that more research in this area is warranted, not less.
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Attentional bias modification (ABM) is an emerging
treatment approach designed to alter patterns of atten-
tional selectivity favouring the processing of threatening
information that are implicated in the development and
maintenance of psychopathology, most notably anxiety
disorders. The last 5 years has seen a rapid expansion in
the volume of research examining the therapeutic bene-
fits of ABM. On balance, results have been very encour-
aging, with more than 20 studies now demonstrating
that the modification of selective attention for threat can
reduce levels of anxiety vulnerability [1]. In addition to
these positive results, some recent studies have failed to
demonstrate clinical benefits under specific conditions.
One of the most recent of these was the randomised
control trial by Carlbring and colleagues [2] which failed
to modify biased attention and anxiety symptoms among a
group of socially anxious individuals. While the old scientific* Correspondence: patrick.clarke@uwa.edu.au
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reproduction in any medium, provided the ortruism reminds us not to mistake absence of evidence as
evidence of absence, a recent review of ABM research ap-
pears to have made such a mistake in suggesting that
current empirical findings provide reason to believe that
attentional bias modification has little potential as a thera-
peutic tool. This brief review by Emmelkamp [3] draws in-
spiration from the tale of the Emperor’s New Clothes. In
this story, despite the total absence of objective evidence
supporting the existence of the garment, the protagonist,
for socially motivated reasons, chooses to act as if such
evidence existed. Emmelkamp’s review suggests that this
same phenomenon may apply to those who profess to be-
lieve the validity of empirical findings regarding the clin-
ical benefits of attentional bias modification, who choose
to do so despite the absence of objective evidence. Indeed,
Emmelkamp goes so far as to conclude that that the
weight of current empirical evidence suggests that “…
there is no need yet to investigate the implementation of
attentional bias modification through the internet” (p1). In
making this suggestion we believe that the review is per-
haps showing more similarity with an alternative true tale,
originating in the 1801 Battle of Copenhagen featuring onetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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a signal to withdraw his ships, which he did not wish to ac-
knowledge, Nelson, in an act of motivated denial of object-
ively identifiable evidence, raised his telescope to his one
blinded eye, and commented “I really do not see the signal”,
thus coining the phrase ‘turning a blind eye’. While we do
not believe that Emmelkamp’s recent commentary on ABM
has sought to engage in the same motivated denial of
current evidence as Nelson, it seems that on the issue of
empirical support for ABM, not only has this been ob-
served through an overly narrow scope, but the scope may
have been selectively directed, and the resulting vision com-
promised to an extent that limits the voracity of the conclu-
sions concerning the objective state of the field. The
following seeks to briefly consider recent findings within
the context of the emergence of ABM from experimental
psychopathology, reviews the current evidence regarding
the therapeutic potential of ABM, and considers whether
recent failed ABM implementations provides adequate rea-
son to abandon ABM as a potential clinical intervention.
The emergence of ABM from experimental
psychopathology
Attentional bias modification can be considered a product
of the relatively new field of psychological research broadly
termed experimental psychopathology. The principal goal
of experimental psychopathology has been to establish the
low level patterns of information processing (such as atten-
tion and interpretation) that contribute to emotional path-
ology. More recently however, researchers in this field have
sought to develop cognitive-experimental technologies
capable of modifying biased patterns of information pro-
cessing to produce clinical benefits. Some have expressed
frustration that two decades of experimental psycho-
therapy research has resulted in little clinical applica-
tion [3], with cognitive bias modification (including
ABM) emerging as one of the few promising products
of these enquiries. While we sympathise with such
frustration (scientific progress being almost invariably
slow), it is important to consider the emergence of this
in the context of the development of previous treat-
ment approaches. A backward glance reminds us that
more than half a century elapsed between Pavlov spot-
ting the ‘conditioned reflex’ in 1901 and formalisation
of behavioural treatment approaches based on system-
atic desensitisation in the 1950s [4]. It would then be
another half century until innovative researchers, such
as Emmelkamp himself, sought to adapt such treat-
ments to permit online delivery (the creation of the
internet being a necessary precursor). Such a historical
context highlights that, by comparison, the emergence
of cognitive bias modification techniques from expe-
rimental psychopathology appears to have occurred at
blistering speed.It is scarcely a decade since MacLeod and colleagues
[5] provided the first experimental demonstration that
attentional bias for threatening material can be altered,
and that this exerts a direct impact on emotional vulner-
ability. The first work delivering such ABM to clinical
samples began only in the last five years and has ex-
panded rapidly [6]. Three early studies provided compel-
ling evidence that ABM can attenuate the clinical
symptoms of patients suffering from anxiety disorders.
In an RCT, Schmidt et al. [7] found that 72% of individ-
uals diagnosed with social anxiety disorder who com-
pleted eight ABM sessions across 4 weeks no longer met
clinician-rated diagnostic criteria for the disorder post-
treatment, compared to 12% in a non-training control
condition, with gains being maintained at four-month
follow-up. In a similar 4 week design, Amir et al. [8] also
found that, at post-treatment, 50% of those who received
ABM no longer met diagnostic criteria for social anxiety
disorder, compared to 14% in the control condition. A
third study involving patients with generalised anxiety
disorder, conducted by Amir et al. [9], found that eight
sessions of ABM across four weeks resulted in 50% of
those receiving ABM no longer meeting diagnostic cri-
teria, compared to 13% of participants exposed a non-
training control condition. Subsequent studies have also
shown promising results in paediatric anxiety disorders
using home-based delivery of ABM. Waters et al. [10]
revealed that two weeks (12 sessions) of ABM completed
by children with clinical anxiety at home resulted in 50%
of those in active training no longer meeting diagnostic
criteria compared to 8% in the control condition. Others
still have demonstration that ABM can reduce risk fac-
tors for recurrent depressive episodes among vulnerable
individuals as evidenced by reduction in self-reported
depressions symptoms and objective indices of risk such
as cortisol awakening response [11]. By most standards,
the results of these studies could be considered a very
encouraging initial foray of ABM into clinical settings,
and these represent only a fraction of the research which
has demonstrated that the modification of selective at-
tention can have positive emotional consequences [12].
Nevertheless it is important to consider such findings
within the context of the broader ABM literature.
Meta-analytic findings of ABM and their limitations
At least two meta-analyses have now been conducted
providing some general insight as to the therapeutic po-
tential of ABM [12,13]. While these can be a useful tool
for examining the broad evidence in relation to ABM, as
with all meta-analyses, by combining the data of various
studies critical distinctions can be missed. Perhaps most
notably, the Hallion and Ruscio meta-analysis [13] has a
number of serious limitations. Not only did this study
pool the results of both attentional bias modification
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ation of the impact of bias modification was compromised
by inappropriately combining emotional measures. Specif-
ically, they combined emotional effects measured at time
points where there is no expectation that bias modifica-
tion will impact emotion (immediately after cognitive bias
modification but before an emotional stressor in single
session implementations) with time points where it is ex-
pected that bias modification will have an emotional im-
pact (post-treatment in multi-session implementations),
thereby underestimating therapeutic emotional effects and
over-estimating spurious mood effects following the bias
modification tasks. This paper was also highly inclusive of
bias modification studies (e.g. including those with dubi-
ous ABM methods [14]) and handled missing effect sizes
by imputing values of 0.00. Thus, it is somewhat unsur-
prising that estimates of effect sizes across the pooled at-
tentional and interpretive bias modification studies were
small (g = 0.13 – 0.29).
The meta-analysis by Hakamata, et al. [12] by compari-
son includes only studies with computable effect sizes and
focuses exclusively on attentional bias modification, pro-
viding more relevant information on ABM. This paper put
overall estimated effect sizes in the medium range (d =
0.61). Furthermore, it indicated that these effects seem to
be larger amongst patient populations (d = 0.78) as com-
pared to non-patients (d = 0.48). Such clinical effect sizes
begin to compare favourably with traditional psychological
interventions (e.g. d = 0.86; [15]). This seems contrary to
the claim in Emmelkamp’s recent review [3] that there “is
not robust evidence that attention training is of clinical
value”. Indeed, when one considers that effect sizes for
CBT are likely to be enhanced by poorly-matched control
conditions [16] as compared to the tightly matched controls
in ABM, such interventions appear to have considerable
promise. It is important to note however that the studies
included in these meta-analyses do not meet the stringent
criteria of randomised control trials, and indeed, only a mi-
nority of ABM studies conducted to date do. These studies
should therefore be interpreted with caution. Furthermore,
a limitation with both these meta-analyses is that the in-
creasing volume of ABM research means that they have
quickly become dated and do not consider a number of re-
cent findings that have, and have not succeeded in imple-
menting ABM. Thus, despite these generally encouraging
findings it is important to consider these more recent stud-
ies and their broader implications for attentional bias modi-
fication as an emerging treatment approach.
What do recent failures suggest about the potential
effectiveness of ABM?
At the time of its publication, the study by Carlbring
et al. [2] represented the first study to have implemented
an ABM task without therapeutic success within acontrolled trial. There have since been a been a number of
other studies that have delivered intended attentional bias
modification tasks that have neither successfully modified
biased attention or impacted clinical symptomology. Sev-
eral of these have targeted social anxiety disorder [17-20],
with another unsuccessfully attempting to modify biased
attention in sufferers of posttraumatic stress disorder [21].
What has tended to be overlooked in a number of these
studies (e.g. [2]) and within recent reviews of this work
[3], but which is critical to note, is that none of these stud-
ies succeeded in modifying attentional bias. That is, it is
not the case that these studies altered patterns of biased
attention but this failed to influence measures of emo-
tional vulnerability. Rather, they simply failed to alter pat-
terns of selective attention that are known to causally
underpin emotional vulnerability. Without such a change
in attention, a change in emotion therefore cannot be ex-
pected. Hence, these studies represent manipulation fail-
ures, not evidence against the potential therapeutic value
of attentional bias modification. To conclude that atten-
tional bias modification is therapeutically ineffective on
the basis of studies that failed to modify attentional bias
would be akin to drawing the conclusion that the surgical
removal of tumours is an ineffective treatment for cancer
on the basis of studies that performed surgery but failed
to remove any tumours. In each case a procedure has been
performed with the intention of altering a specific target,
but the critical target of the intervention was not achieved.
These studies therefore represent an absence of evidence
for the effectiveness of ABM, but not evidence that ABM
is ineffective.
Indeed, the very fact that the studies which have failed
to modify selective attention have also failed to modify
emotional vulnerability provides reassurance that the the-
oretical basis for ABM is sound. Specifically, it highlights
that when a task achieves its goal of successfully altering
attention, it will reliably produce emotional change, and
when it doesn’t, it won’t. This pattern of effects holds true
more generally across the literature. We compiled a list
of 42 ABM studies (39 papers) conducted to date (see
Additional file 1), of which 29 include measures of both
attentional bias change and emotional vulnerability, and
are therefore able to inform the link between this pro-
posed causal mechanism and its emotional impact. Of
these 29 studies, 26 are entirely consistent with this link in
that when attentional bias modification is achieved so is
the consequent change in emotional vulnerability (n = 16),
and when attentional bias modification is not achieved, no
impact on emotional vulnerability is observed (n = 10). Of
the three remaining studies, one successfully modified at-
tentional bias but observed an impact only on behavioural
measures (willingness to approach a feared stimulus) [22],
and two focused on specific phobias [23,24] which, as
noted elsewhere [6], may be resistant to emotional change
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ies that succeeded in modifying both attention and emo-
tional vulnerability four were conducted with clinical
samples (six sub-clinical), while for those that did not suc-
ceed in modifying attentional bias, seven were conducted
with clinical samples (one sub-clinical). The failure of a
number of studies to modify selective attention should
certainly invite empirical scrutiny into the precise task
conditions and modes of delivery that are most likely to
be effective in producing a bias change. However, they
provide little reason to conclude, as Emmelkamp does [3],
that ABM procedures and the various modalities in which
they may be delivered (e.g. online, portable device) should
not be pursued as a promising form of therapeutic inter-
vention for clinical populations, as the research clearly
tells us that when the modification of attentional bias is
achieved, emotional benefits follow.
Could the positive results of ABM be due to
demand effects?
In his recent review Emmelkamp [3] suggests that ex-
pectancy and demand effects are likely to play a role in
producing positive emotional effects in ABM. The po-
tential influence of demand and expectancy on treat-
ment outcome is an issue of concern for a range of
interventions so it is worth considering whether such ex-
traneous participant factors could potentially carry ef-
fects derived from ABM interventions. It is well known
that the effects of cognitive and behavioural therapeutic
interventions may benefit from poorly-matched control
conditions (such as waitlist) where the comparative ef-
fects from active treatment conditions may be enhanced
by expectancy, demand, and non-specific treatment fac-
tors which are absent in the control group [16]. By com-
parison, ABM resists demand and expectancy effects far
more effectively than the great majority of CBT inter-
ventions due to the quality of the control condition. In
most ABM tasks the control condition is tightly matched
with the treatment condition in virtually all parameters,
except the training contingency. For example, in the at-
tentional probe approach (e.g. [25]), both active ABM
and control conditions present the same stimuli, deliv-
ered at the same time, for the same duration and require
the same response. The only difference between the ac-
tive ABM and control condition is the presence of a con-
tingency between the probe location and the stimulus type
in the active ABM condition (with probes always appearing
in the location of non-threatening stimuli to encourage an
attentional bias away from threat), which is absent in the
control condition. The subtlety of this difference between
control and active ABM conditions means that researchers
can confidently rule out the influence of non-specific fac-
tors as potential therapeutic agents (e.g. such as stimulus
exposure). Also, because of this small difference betweenconditions, participants consequently are likely to have no
awareness of whether or not they are in fact receiving an
active intervention, which means there is little capacity for
demand or expectancy effects to selectively influence
the treatment condition and not the control condition.
When ABM researchers have sought to examine partici-
pant awareness of their allocation to treatment condi-
tions they have found that most (79% of those in the
control condition and 72% of those in the ABM con-
dition) believe that they are not receiving an active
treatment at all, with no significant differences in this
awareness between conditions [8].
While Emmelkamp’s review proposes that ABM find-
ings may be due to demand effects it provides no sug-
gestions about how such effects could occur. Indeed,
when one considers how demand and expectancy could
contribute to the effects observed in ABM it becomes
apparent that this would have to be so highly systematic
as to stretch credulity. Participants would need to be
aware of the purpose of ABM tasks and feign the acqui-
sition of an attentional bias only in the active ABM con-
dition and not the control. Even if this were plausible,
the review also fails to engage with the vexing issue of
how such demand characteristics happen to produce
emotional benefits in only those studies that successfully
modify selective attention and not in those which have
failed to do so. Thus, it seems that the burden of demand
and expectancy effects does not weigh heavily on ABM re-
search, but instead falls upon studies that involve compari-
son of active psychotherapeutic treatments and waitlist
controls. This includes the type of internet-based treatment
promoted in Emmelkamp’s recent review as one of the key
reasons that researchers do not need to investigate online
delivery of ABM [26].
Is there any need for attentional bias modification as
an intervention?
Perhaps the most provocative element of Emmelkamp’s
recent review [3] is the insistence that current evidence
suggests “…there is no need yet to investigate the imple-
mentation of attentional bias modification through the
internet” (p1, emphasis added). It seems that despite
clear evidence that altering biased attention for threat
can reduce emotional vulnerability, and encouraging re-
sults with clinical samples, the failure of a number of
studies to modify selective attention should be grounds
for all researchers to cease investigations into the clinical
applications of attentional bias modification using the
internet. By way of justification, Emmelkamp cites find-
ings of internet-delivered treatment for social anxiety
from his own research group. This study certainly pro-
duced very respectable between-group effect sizes (d =
0.86) for those receiving active treatment. However, the
implication that the efficacy of an existing intervention
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ment approaches need not be investigated is a curious
one, quite antithetical to the cycle of innovation, refine-
ment, and improvement that characterises scientific pro-
gress. It also ignores the potential advantages of ABM
interventions in terms of their simplicity and brevity com-
pared to ‘brief ’ CBT approaches taking 6–12 weeks in-
corporating psycho-education, cognitive restructuring,
exposure and behavioural experiment components. In
contrast, two 15 minute ABM sessions a week for four
weeks have been shown to achieve within-group treat-
ment effect sizes of up to d = 1.92 for social anxiety dis-
order [8] and d = 1.40 for generalised anxiety disorder [9]
with follow-up data suggesting that benefits are main-
tained over time. Hence, it is difficult to understand the
basis for suggesting that the existence of effective online
interventions should preclude researchers from investigat-
ing what is a promising alternative treatment approach.
The fact that that patterns of biased information known to
characterise anxiety pathology can be directly targeted by
computer-based ABM tasks that can be delivered remotely
suggests such interventions hold significant potential as ei-
ther a stand-alone or complimentary intervention for anx-
iety disorders that may be ideally suited to online delivery.
Thus, unlike Emmelkamp, we believe that the current evi-
dence provides compelling reasons to investigate online de-
livery of ABM, and we would encourage more research in
this area, not less.
Future research
On one issue we believe we are in complete agreement
with Emmelkamp. That is, ABM is not ready for wide-
scale dissemination as a mainstream intervention, nor
should it yet be directly marketed to mental health con-
sumers. The number of therapeutic successes observed
provides a tantalising demonstration of what ABM is
capable of, while the failures to consistently modify
biased attention for threat highlights the need for more
reliable means of achieving change in the target cogni-
tive process. Thus, as is the case for any fledgling psy-
chotherapeutic intervention, an early objective for ABM
researchers must be to optimise capacity to modify the
target process; namely, biased attentional response to
negative information. The observation that the mag-
nitude of attentional change elicited by ABM treatment
predicts the magnitude of change in emotional symp-
tomology [12] suggests that as ABM tasks get better
at achieving attentional change, so too will they become
more effective in alleviating emotional dysfunction. All
of the findings reviewed here have utilised variants
of the attentional probe task originally developed by
MacLeod et al. [5]. However, it is highly improbable that
the first ABM task ever developed will prove to be the
best at producing robust and enduring attentional change.As researchers seek to refine and enhance current ABM
tasks and develop innovative new approaches, we can ex-
pect to see progressive improvement in their attentional
impact. In this regard we can be confident that ABM has
not peaked. Such future research will likely shed light on
the reasons why particular studies have failed to alter se-
lective attention, whereas others have succeeded. For ex-
ample, it would be interesting to investigate whether
participants’ belief that they are not receiving active treat-
ment (when they are in fact being delivered ABM) re-
duces task adherence and the attentional and emotional
benefits of ABM. While the formality of a lab environ-
ment may contribute to task engagement regardless of
beliefs concerning treatment condition, being convinced
that one is not receiving treatment could have greater
consequence for motivation and engagement among
those who complete ABM tasks at home. If this is in-
deed the case, it would be critical for future studies to
carefully consider the type of instructions that partici-
pants receive to ensure that task engagement is not
compromised. Additionally, future research could use-
fully seek to establish how ABM may best be incorpo-
rated with traditional therapeutic approaches to
enhance clinical outcomes. This will help to identify
whether ABM may best be used as a precursor to psy-
chotherapy, delivered simultaneously with other inter-
ventions, or if it can assist in the maintenance of gains
and prevention of relapse via administration post-
therapy.
Conclusions
ABM has produced many positive findings that con-
firm its capacity to attenuate emotional vulnerability in
non-clinical samples and to reduce the symptoms of
emotional dysfunction in clinical patients. The fact
that some studies have failed to successfully modify se-
lective attention, and consequently have not modified
emotional vulnerability, suggests that more work re-
mains to be done in order to identify the conditions
under which ABM is likely to be most effective in pro-
ducing the target attentional change. This observation
underscores the importance of increasing, not redu-
cing research into ABM approaches. Our knowledge of
the precise conditions under which exposure-based
treatments can effectively reduce anxiety has come a
long way in the century since Pavlov first began ringing
bells and collecting saliva. The early and continuing
successes of ABM approaches suggest that this and
other cognitive bias modification techniques are likely
to have a bright future. Undoubtedly, the attainment of
this bright future will depend upon the investment of
sustained and creative research effort. One would be
well advised to watch this space rather than turn a
blind eye.
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